Dual-Acting Antiangiogenic Gene Therapy Reduces Inflammation and Regresses Neovascularization in Diabetic Mouse Retina

Intravitreal injections of anti-vascular endothelial growth factor drugs have become the gold standard treatment for diabetic retinopathy (DR). However, several patients are classified as non-responders or poor responders to treatment. Therefore, it is essential to study alternative target molecules...

Descripción completa

Detalles Bibliográficos
Autores principales: Araújo, Rute S., Bitoque, Diogo B., Silva, Gabriela A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527613/
https://www.ncbi.nlm.nih.gov/pubmed/33230438
http://dx.doi.org/10.1016/j.omtn.2020.08.036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527613/
https://www.ncbi.nlm.nih.gov/pubmed/33230438
http://dx.doi.org/10.1016/j.omtn.2020.08.036

Ejemplares similares